![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
The item has been added to your shopping cart.
Home » Neuronetics Receives 510(k) Clearance for D-Tect MT Accessory
Neuronetics Receives 510(k) Clearance for D-Tect MT Accessory
August 30, 2022
Malvern, Pa.-based Neuronetics has received 510(k) clearance from the FDA for its D-Tect MT motor threshold mapping accessory.
The device visually reports the magnitude of finger movements during motor threshold mapping for the treatment of major depressive disorder. Motor threshold is an indicator used to determine transcranial magnetic stimulation levels for patient response.
The accessory, which is designed to recognize movement in three areas of the hand, does not require cords or sensors to be attached to the patient. The device is intended to be used with two of the company’s NeuroStar products, Fast MT and MT Cap.
The D-Tect MT device “aids physicians as they determine the treatment location and treatment level for new patients,” the company said.
Upcoming Events
-
21Oct